Among emerging biomarkers, interleukin-6 (IL-6 pg/mL), a master regulator of inflammation, has consistently been associated with left ventricular hypertrophy, progression of heart failure, and increased mortality [8]. This evidence concerns the gene IL6 and left ventricular hypertrophy.